NEW YORK – Preventive genomics medicine company Veritas Intercontinental said on Thursday that it has completed a €5 million ($5.8 million) Series B financing round.
The round was led by Charme Capital Partners and Amadeus Capital Partners, who have invested in the Veritas Genetics spinoff firm since it was founded in 2018. They were joined in the Series B round by Stemar Capital Partners and entrepreneur Graham Snudden.